Fractional Laser Treatment Boosts Systemic Anti-Tumor Immunity in Combination with OX40 Agonist and PD-1 Blockade
M. Kawakubo, J. Glahn, Z. Tao, S. Demehri, D. Manstein
This study shows that combining fractional laser treatment with PD-1 blockade and OX40 agonist significantly reduces tumor growth and induces complete remission in mice.
bioRxiv · Nov 29, 2021 · PreprintImmunology